Pfizer's chief corporate affairs officer, Sally Susman, recounts how the company managed the massive communications challenge that came with Covid-19 and the race to produce an effective vaccine ...

Sally Susman is Executive Vice President and Chief Corporate Affairs Officer at Pfizer. Before joining Pfizer in 2007, she held roles at Estée Lauder Companies and the American Express Company.

Pfizer' Communications and Policy Chief Sally Susman has made a name for herself doing just that, such as by helping the pharmaceutical giant launch its COVID-19 vaccine at the height of the pandemic.

(MENAFN - PRovoke) NEW YORK - Sally Susman, Pfizer's executive VP and chief corporate affairs officer, will depart the pharmaceutical giant at the end of the year after 18 years with the company.

Sally Susman, Executive Vice President and Chief Corporate Affairs Officer at Pfizer, provides insights from her newly released book, Breaking Through, to help leaders based on her expertise and ...

Susman described the moment when Pfizer’s top brass, huddled in a small Connecticut office, learned the vaccine worked. “We had over 44,000 people in our clinical trials,” she said.

Big is not necessarily bad, says Pfizer PR supremo Sally Susman. “Big can be a force for good.” Susman, who is EVP policy, external affairs and communications at Pfizer, has the unenviable task of ...

Biggest professional win: Susman helped Pfizer manage their Covid-19 response and convey the safety and efficacy of its vaccine by persuading scientists to post intellectual property on their website.

“Pfizer shot us all in the collective foot,” an unnamed source told the Times. Although Susman declined to be interviewed by the Times, the piece drew from an unattributed 2011 profile of Susman in MM ...

Pfizer’s executive vice president and chief corporate affairs officer joins "Morning Joe" co-host Mika Brzezinski on her podcast, "Mika Straight Up," to share lessons about communicating ...